Gerald continues to deliver incremental steps building a world class company! His decision to delay release of the specific data on LYMPRO was I believe brilliant! His purpose in Copenhagen was to get the attention of the AD researchers and Pharmas, which has now been accomplished. Like a chess-master he is now proceeding to his next move, castling, preparing to release the specific data instead at the TBI summit at the UN in the end of July. He already has the attention now of the world community from the AAIC, researchers, and Pharma, and he will now reveal at the World TBI conference in NYC the stunning specific of LYMPROS! Checkmate. Nothing more than a fantastic opportunity to add to your position if the manipulation continues. Well done Gerald!
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links